BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 895887)

  • 1. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
    Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
    Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
    [No Abstract]   [Full Text] [Related]  

  • 2. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides.
    Bult H; Bonta IL
    Nature; 1976 Dec; 264(5585):449-51. PubMed ID: 1004576
    [No Abstract]   [Full Text] [Related]  

  • 3. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.
    Samuelsson B; Hamberg M; Malmsten C; Svensson J
    Adv Prostaglandin Thromboxane Res; 1976; 2():737-46. PubMed ID: 983874
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV; Johnson RA; Gorman RR
    Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction.
    Raz A; Minkes MS; Needleman P
    Biochim Biophys Acta; 1977 Aug; 488(2):305-11. PubMed ID: 560869
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane A2 and prostaglandin H2: potent stimulators of the swine coronary artery.
    Svensson J; Hamberg M
    Prostaglandins; 1976 Dec; 12(6):943-50. PubMed ID: 1005743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel transformations of prostaglandin endoperoxides: formation of thromboxanes.
    Hamberg M; Svensson J; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():19-27. PubMed ID: 1033661
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes.
    Needleman P; Kulkarni PS; Raz A
    Science; 1977 Jan; 195(4276):409-12. PubMed ID: 831285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.
    Smith JB; Ingerman C; Silver MJ
    J Clin Invest; 1976 Nov; 58(5):1119-22. PubMed ID: 993335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxanes: selective biosynthesis and distinct biological properties.
    Needleman P; Minkes M; Raz A
    Science; 1976 Jul; 193(4248):163-5. PubMed ID: 945611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Formation of prostaglandin endoperoxides and rabbit aorta contracting substance (RCS) by coupling two enzyme systems.
    Bunting S; Moncada S; Needleman P; Vane JR
    Br J Pharmacol; 1976 Mar; 56(3):344P-345P. PubMed ID: 944058
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2.
    Chignard M; Vargaftig BB
    Prostaglandins; 1977 Aug; 14(2):222-40. PubMed ID: 197571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
    MacIntyre DE; Salzman EW; Gordon JL
    Biochem J; 1978 Sep; 174(3):921-9. PubMed ID: 215124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of prostaglandin endoperoxides on platelet ultrastructure.
    Gerrard JM; White JG
    Am J Pathol; 1975 Aug; 80(2):189-202. PubMed ID: 169697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Hydroperoxyeicosatetraenoic acid inhibits human platelet aggregation.
    Vericel E; Lagarde M
    Lipids; 1980 Jun; 15(6):472-4. PubMed ID: 7401944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes.
    Kulkarni PS; Eakins KE
    Prostaglandins; 1976 Sep; 12(3):465-9. PubMed ID: 968059
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.